ARVEE LABORATORIES (INDIA)
|
ARVEE LABORATORIES (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.95 | 3.74 | 2.34 | 2.43 | 4.17 |
| CEPS(Rs) | 2.31 | 5.63 | 4.44 | 4.61 | 4.16 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 26.42 | 25.46 | 21.72 | 19.39 | 33.82 |
| Tax Rate(%) | 42.51 | 33.19 | 25.38 | 26.48 | 25.61 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.68 | 11.87 | 13.95 | 12.75 | 13.26 |
| EBIT Margin(%) | 6.85 | 10.68 | 9.47 | 8.90 | 8.98 |
| Pre Tax Margin(%) | 6.03 | 10.05 | 8.55 | 7.69 | 6.80 |
| PAT Margin (%) | 3.47 | 6.71 | 6.38 | 5.65 | 5.06 |
| Cash Profit Margin (%) | 8.40 | 10.10 | 12.14 | 10.73 | 10.10 |
| Performance Ratios | |||||
| ROA(%) | 2.72 | 10.65 | 6.46 | 7.17 | 6.50 |
| ROE(%) | 3.68 | 15.84 | 11.36 | 13.38 | 13.17 |
| ROCE(%) | 7.03 | 23.35 | 13.33 | 15.99 | 15.79 |
| Asset Turnover(x) | 0.79 | 1.59 | 1.01 | 1.27 | 1.28 |
| Sales/Fixed Asset(x) | 0.97 | 2.03 | 1.41 | 1.83 | 1.97 |
| Working Capital/Sales(x) | 3.08 | 4.82 | 3.97 | 6.53 | 8.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.04 | 0.49 | 0.71 | 0.55 | 0.51 |
| Receivable days | 110.50 | 72.55 | 90.55 | 55.46 | 57.98 |
| Inventory Days | 65.94 | 30.63 | 59.55 | 53.54 | 44.51 |
| Payable days | 180.60 | 82.15 | 157.69 | 121.18 | 100.36 |
| Valuation Parameters | |||||
| PER(x) | 150.24 | 23.54 | 48.68 | 22.80 | 5.63 |
| PCE(x) | 61.97 | 15.64 | 25.60 | 12.01 | 5.64 |
| Price/Book(x) | 5.43 | 3.46 | 5.23 | 2.86 | 1.39 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 5.18 | 1.58 | 3.07 | 1.34 | 0.63 |
| EV/Core EBITDA(x) | 43.93 | 11.25 | 20.16 | 9.56 | 4.52 |
| EV/EBIT(x) | 75.60 | 14.81 | 32.41 | 15.01 | 7.06 |
| EV/CE(x) | 5.22 | 3.34 | 3.20 | 1.54 | 0.86 |
| M Cap / Sales | 5.21 | 1.58 | 3.11 | 1.29 | 0.57 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -50.54 | 52.12 | -14.88 | 4.31 | -17.27 |
| Core EBITDA Growth(%) | -58.57 | 40.61 | -7.32 | 4.04 | -2.47 |
| EBIT Growth(%) | -68.28 | 71.58 | -9.45 | 3.42 | -2.38 |
| PAT Growth(%) | -74.46 | 60.04 | -3.87 | 16.46 | 1.60 |
| EPS Growth(%) | -74.46 | 60.03 | -3.86 | -41.77 | 1.60 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.04 | 0.13 | 0.42 | 0.21 |
| Current Ratio(x) | 2.35 | 2.44 | 1.75 | 1.40 | 1.43 |
| Quick Ratio(x) | 1.47 | 1.92 | 1.33 | 0.99 | 0.91 |
| Interest Cover(x) | 8.33 | 16.89 | 10.31 | 7.32 | 4.13 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.02 | 0.15 | 0.15 |
Compare Financial Ratios of peers of ARVEE LABORATORIES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ARVEE LABORATORIES (INDIA) | ₹191.9 Cr | -4.8% | 7.3% | 1.8% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹148,799.0 Cr | 0.5% | -7% | 5.3% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹87,806.1 Cr | -4.6% | -7.1% | 46.3% | Stock Analytics | |
| SRF | ₹65,896.7 Cr | -1.6% | -3.8% | -10.8% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹46,502.2 Cr | -3.7% | 4.5% | 14.3% | Stock Analytics | |
| DEEPAK NITRITE | ₹34,285.8 Cr | -2.6% | -4.3% | 0.7% | Stock Analytics | |
ARVEE LABORATORIES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ARVEE LABORATORIES (INDIA) | -4.8% |
7.3% |
1.8% |
| SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses
